Myron Czuczman - Oct 10, 2023 Form 4 Insider Report for Citius Pharmaceuticals, Inc. (CTXR)

Role
Chief Medical Officer
Signature
/s/ Alexander M. Donaldson, by power of attorney
Stock symbol
CTXR
Transactions as of
Oct 10, 2023
Transactions value $
$0
Form type
4
Date filed
10/12/2023, 04:15 PM
Previous filing
Oct 6, 2022
Next filing
Aug 14, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTXR Stock Option (Right to Purchase Common Stock) Award $0 +300K $0.00 300K Oct 10, 2023 Common Stock 300K $0.70 Direct F1
holding CTXR Stock Option (Right to Purchase Common Stock) 300K Oct 10, 2023 Common Stock 300K $1.25 Direct F2
holding CTXR Stock Option (Right to Purchase Common Stock) 300K Oct 10, 2023 Common Stock 300K $2.04 Direct F3
holding CTXR Stock Option (Right to Purchase Common Stock) 500K Oct 10, 2023 Common Stock 500K $1.19 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F2 The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F3 The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F4 The options vested on July 14, 2022.